CAR NK cell therapy bolsters the body’s innate ability to fight cancer by attaching molecules called chimeric antigen receptors (CAR) to natural killer cells (NK cells). These receptors allow the newly enhanced CAR NK cells to recognize targets on the surface of previously “invisible” cancer cells and attack them.    

At MD Anderson, this novel form of immunotherapy was initially offered only through clinical trials to...